Phase 2 proof-of-concept study investigating the efficacy of navarixin in patients with chronic obstructive pulmonary disease

Trial Profile

Phase 2 proof-of-concept study investigating the efficacy of navarixin in patients with chronic obstructive pulmonary disease

Completed
Phase of Trial: Phase II

Latest Information Update: 28 May 2013

At a glance

  • Drugs Navarixin (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 May 2013 Primary endpoint 'Forced-expiratory-volume-in-1-second' has been met.
    • 28 May 2013 New trial record
    • 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top